NCT07068711 Nutritional Status of Head and Neck Cancer Patients
| NCT ID | NCT07068711 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Marmara University |
| Condition | Head and Neck Cancer |
| Study Type | OBSERVATIONAL |
| Enrollment | 57 participants |
| Start Date | 2025-07-01 |
| Primary Completion | 2026-06-25 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 57 participants in total. It began in 2025-07-01 with a primary completion date of 2026-06-25.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study aims to monitor the nutritional status of patients with head and neck cancer undergoing radiotherapy treatment. Throughout the treatment process, patients' body composition, handgrip strength, food intake, quality of life, and treatment-related side effects will be regularly assessed. Measurements will include physical parameters like body weight, height, and waist circumference, as well as blood test results and nutrition-related questionnaires. By closely tracking these changes, the study seeks to identify early signs of nutritional deterioration and support timely interventions. The goal is to better understand nutrition-related challenges during treatment and ultimately improve patients' quality of life.
Eligibility Criteria
Inclusion Criteria: * Patients aged 18 years and older * Diagnosed with head and neck cancer * Receiving radiotherapy at Marmara University Pendik Training and Research Hospital, Radiation Oncology Clinic * Willing to participate and able to provide written informed consent * Able to communicate and cooperate during assessments Exclusion Criteria: * Patients for whom BIA measurement is not possible (e.g., caffeine intake within the last 4 hours, alcohol use in the last 24 hours, intense physical activity in the last 24-48 hours, menstruation, presence of pacemaker or metal implants) * Patients with communication barriers or cognitive impairments * Amputees or individuals with severe upper extremity deformities * Patients with neuromuscular disorders, hemiplegia, rheumatoid arthritis, or moderate/severe neurological or cognitive impairment * Patients receiving parenteral nutrition
Contact & Investigator
Beste M Atasoy, Prof. Dr.
STUDY DIRECTOR
Marmara University
Frequently Asked Questions
Who can join the NCT07068711 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Head and Neck Cancer. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07068711 currently recruiting?
Yes, NCT07068711 is actively recruiting participants. Contact the research team at zcelik@marmara.edu.tr for enrollment information.
Where is the NCT07068711 trial being conducted?
This trial is being conducted at Istanbul, Turkey (Türkiye).
Who is sponsoring the NCT07068711 clinical trial?
NCT07068711 is sponsored by Marmara University. The principal investigator is Beste M Atasoy, Prof. Dr. at Marmara University. The trial plans to enroll 57 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.